Jeffrey C. Boehm

3.7k citations

35 papers · 2.9k indexed · 1 hit paper · h-index 19

Molecular Biology top 5%
Organic Chemistry top 2%
Oncology top 5%
Computational Theory and Mathematics top 2%
Immunology top 10%

Co-authors: John C. LeeSanjay KumarJerry L. Adams William D. Kingsbury Sherin S. Abdel‐Meguid Kenneth G. Holden Bertram Canagarajah Mary Jo Caranfa
Topics: Melanoma and MAPK Pathways (9 papers)Chemical Synthesis and Analysis (7 papers)Synthesis and biological activity (7 papers)
Cited by: Toxicology Organic Chemistry Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society Journal of Biological Chemistry
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Jeffrey C. Boehm

35 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases

2003 1.0k citations Sanjay Kumar, Jeffrey C. Boehm et al. Nature Reviews Drug Discovery profile →

Peers

Countries citing papers authored by Jeffrey C. Boehm

Since Specialization

Citations

This map shows the geographic impact of Jeffrey C. Boehm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey C. Boehm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey C. Boehm more than expected).

Fields of papers citing papers by Jeffrey C. Boehm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey C. Boehm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey C. Boehm. The network helps show where Jeffrey C. Boehm may publish in the future.

Co-authorship network of co-authors of Jeffrey C. Boehm

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey C. Boehm. A scholar is included among the top collaborators of Jeffrey C. Boehm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey C. Boehm. Jeffrey C. Boehm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An improved and highly convergent synthesis of 4-substituted-pyrido[2,3-d]pyrimidin-7-ones 2007 ·Tetrahedron Letters ·Hongxing Yan,Jeffrey C. Boehm,Qi Jin,Jiri Kasparec,Huijie Li,(unknown),Katherine L. Widdowson,James F. Callahan,Zehong Wan	8
2	p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesbreakdown → 2003 ·Nature Reviews Drug Discovery ·Sanjay Kumar,Jeffrey C. Boehm,John C. Lee	1014
3	N-Phenyl-N-purin-6-yl ureas: The design and synthesis of p38α MAP kinase inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Zehong Wan,Jeffrey C. Boehm,Michael J. Bower,Shouki Kassis,John C. Lee,Baoguang Zhao,Jerry L. Adams	23
4	Phenoxypyrimidine inhibitors of p38α kinase 2001 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey C. Boehm,Michael J. Bower,Timothy F. Gallagher,Shouki Kassis,Stephen R. Johnson,Jerry L. Adams	34
5	Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity 2001 ·Bioorganic & Medicinal Chemistry Letters ·Jerry L. Adams,Jeffrey C. Boehm,Timothy F. Gallagher,Shouki Kassis,Edward F. Webb,Ralph Hall,Margaret E. Sorenson,Ravi S. Garigipati,Don E. Griswold,John C. Lee	89
6	Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis 2000 ·Arthritis & Rheumatism ·Alison M. Badger,Don E. Griswold,Rasesh Kapadia,Simon Blake,Barbara A. Swift,(unknown),George B. Stroup,Edward F. Webb,David J. Rieman,Maxine Gowen,Jeffrey C. Boehm,Jerry L. Adams,John C. Lee	186
7	New inhibitors of p38 kinase 2000 ·Expert Opinion on Therapeutic Patents ·Jeffrey C. Boehm,Jerry L. Adams	66
8	Pyrimidinylimidazole inhibitors of CSBP/P38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes 1998 ·Bioorganic & Medicinal Chemistry Letters ·Jerry L. Adams,Jeffrey C. Boehm,Shouki Kassis,Peter D. Gorycki,Edward F. Webb,Ralph Hall,Margaret E. Sorenson,John C. Lee,Andrew D. Ayrton,Don E. Griswold,Timothy F. Gallagher	88
9	Structural basis of inhibitor selectivity in MAP kinases 1998 ·Structure ·(unknown),Bertram Canagarajah,Jeffrey C. Boehm,(unknown),Melanie H. Cobb,Peter R. Young,Sherin S. Abdel‐Meguid,Jerry L. Adams,Elizabeth J. Goldsmith	358
10	The syntheses of 3β-steroidal diacylglyceryl sulfides, sulfoxides, and sulfones 1995 ·Steroids ·John Williams,Jeffrey C. Boehm	10
11	The synthesis and reactivity of 3β-(2-alkynylsulfonyl)- and 3β-(2-alkynylsulfonylmethyl) androst-5-en-17-ones as inhibitors of glucose-6-phosphate dehydrogenase 1995 ·Steroids ·John R. Williams,Jeffrey C. Boehm	14
12	Studies on the synthesis of dehydroepiandrosterone (DHEA) phosphatide 1995 ·Steroids ·John Williams,Jeffrey C. Boehm	3
13	Synthesis of structural analogs of leukotriene B4 and their receptor binding activity 1993 ·Journal of Medicinal Chemistry ·William D. Kingsbury,Israil Pendrak,Jack D. Leber,Jeffrey C. Boehm,(unknown),Henry M. Sarau,(unknown),Dulcie B. Schmidt,R. A. DAINES	12
14	Synthesis and LTB4 receptor antagonist activities of the naturally occurring LTB4 receptor antagonist leucettamine A and related analogs 1993 ·Journal of Medicinal Chemistry ·Jeffrey C. Boehm,John G. Gleason,Israil Pendrak,Henry M. Sarau,Dulcie B. Schmidt,James J. Foley,William D. Kingsbury	26
15	A symmetric inhibitor binds HIV-1 protease asymmetrically 1993 ·Biochemistry ·Geoffrey B. Dreyer,Jeffrey C. Boehm,Balan Chenera,Renée L. DesJarlais,Anne M. Hassell,Thomas D. Meek,Thaddeus A. Tomaszek,(unknown)	58
16	Synthesis of C2-symmetric and pseudosymmetric HIV-1 protease inhibitors from D-arabitol 1991 ·Bioorganic & Medicinal Chemistry Letters ·Balan Chenera,Jeffrey C. Boehm,Geoffrey B. Dreyer	38
17	Multiplicity of peptide permeases in Candida albicans: evidence from novel chromophoric peptides 1985 ·Journal of Bacteriology ·Peter J. McCarthy,L. J. Nisbet,Jeffrey C. Boehm,William D. Kingsbury	23
18	A novel peptide delivery system involving peptidase activated prodrugs as antimicrobial agents. Synthesis and biological activity of peptidyl derivatives of 5-fluorouracil 1984 ·Journal of Medicinal Chemistry ·William D. Kingsbury,Jeffrey C. Boehm,R. J. Mehta,Sarah F. Grappel,Charles Gilvarg	62
19	Portage of various compounds into bacteria by attachment to glycine residues in peptides 1984 ·Proceedings of the National Academy of Sciences ·William D. Kingsbury,Jeffrey C. Boehm,David K. Perry,Charles Gilvarg	34
20	Photochemistry of bicyclo[3.2.0]hept-3-en-2-ones 1973 ·Journal of the American Chemical Society ·Robert L. Cargill,(unknown),Jeffrey C. Boehm,M. Robert Willcott	10

About Jeffrey C. Boehm

Jeffrey C. Boehm is a scholar working on Organic Chemistry, Molecular Biology and Microbiology, having authored 35 papers that have together received 2.9k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (9 papers), Chemical Synthesis and Analysis (7 papers) and Synthesis and biological activity (7 papers). The work is most often cited by research in Toxicology (165 citations), Organic Chemistry (923 citations) and Molecular Biology (1.8k citations). Jeffrey C. Boehm has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include John C. Lee, Sanjay Kumar, Jerry L. Adams, William D. Kingsbury, Sherin S. Abdel‐Meguid, Kenneth G. Holden, Bertram Canagarajah, Mary Jo Caranfa, Melanie H. Cobb and Dalia R. Jakas. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact